Advertisement

Topics

Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants

2019-04-18 12:14:31 | BioPortfolio

Published on BioPortfolio: 2019-04-18T12:14:31-0400

Clinical Trials [1109 Associated Clinical Trials listed on BioPortfolio]

Pilot Removal of Palpable Subdermal Contraceptive Rod Implants

There are no implant removal devices on the market by any manufacturer. Overall, the RemovAid™ combines the features of fixation, incision and extraction. This combination of functions h...

Removal of Palpable Subdermal Contraceptive Rod Implants.

There are no implant removal devices on the market by any manufacturer. New features are described in comparison with the existing removal technique. Overall, the RemovAid™ combines the ...

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

This study will investigate in-office ultrasound localization vs localization in radiology for identification and removal of non palpable etonogestrel (ENG) contraceptive implants and aims...

Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial

The investigators goal is to measure the impact of timing of postpartum contraceptive implant insertion on breastfeeding success and duration and to explore women's experiences with and at...

Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant

To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving bir...

PubMed Articles [4303 Associated PubMed Articles listed on BioPortfolio]

Systematic review of efficacy with extending contraceptive implant duration.

Extending contraceptive implant duration of use increases accessibility by maximizing the lifetime of devices.

Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.

To determine whether serum etonogestrel concentrations in contraceptive implant users are associated with certain individual patient characteristics.

Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.

The aim of the study was to assess the serum levels of the following biomarkers in women with endometriosis-associated pelvic pain before and after six months of using the etonogestrel (ENG) contracep...

Complications of implant removal in ankle fractures.

Although the complications of internal fixation in ankle fractures are well-known in a number of reports, there have been few reports revealing the complications of implant removal in ankle fractures....

Transient heat transfer in dental implants for thermal necrosis-aided implant removal: A 3D finite element analysis.

Removal of osseointegrated but otherwise failed (mechanical failure, mispositioning, aesthetics, etc.) dental implants is a traumatic process resulting in loss of healthy bone and complicating the tre...

Medical and Biotech [MESH] Definitions

The rate of success or failure of a method of CONTRACEPTION; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.

Surveys that measure the usage rate of CONTRACEPTIVE DEVICES or CONTRACEPTIVE AGENTS.

Insertion of an implant into the bone of the mandible or maxilla. The implant has an exposed head which protrudes through the mucosa and is a prosthodontic abutment.

Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.

Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.

More From BioPortfolio on "Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial